Document is current
Any future updates will be listed below
-
Authors
Lake, Blue B.
Menon, Rajasree
Winfree, Seth https://orcid.org/0000-0002-2396-5871
Hu, Qiwen https://orcid.org/0000-0003-2798-919X
Melo Ferreira, Ricardo https://orcid.org/0000-0003-2063-9744
Kalhor, Kian
Barwinska, Daria https://orcid.org/0000-0002-0776-3030
Otto, Edgar A.
Ferkowicz, Michael
Diep, Dinh
Plongthongkum, Nongluk
Knoten, Amanda
Urata, Sarah
Mariani, Laura H.
Naik, Abhijit S.
Eddy, Sean
Zhang, Bo
Wu, Yan
Salamon, Diane
Williams, James C.
Wang, Xin
Balderrama, Karol S.
Hoover, Paul J.
Murray, Evan
Marshall, Jamie L.
Noel, Teia
Vijayan, Anitha
Hartman, Austin
Chen, Fei https://orcid.org/0000-0003-2308-3649
Waikar, Sushrut S. https://orcid.org/0000-0003-4004-326X
Rosas, Sylvia E.
Wilson, Francis P. https://orcid.org/0000-0002-2633-2412
Palevsky, Paul M. https://orcid.org/0000-0002-7334-5400
Kiryluk, Krzysztof
Sedor, John R.
Toto, Robert D.
Parikh, Chirag R.
Kim, Eric H. https://orcid.org/0000-0002-0284-8342
Satija, Rahul https://orcid.org/0000-0001-9448-8833
Greka, Anna
Macosko, Evan Z. https://orcid.org/0000-0002-2794-5165
Kharchenko, Peter V. https://orcid.org/0000-0002-6036-5875
Gaut, Joseph P.
Hodgin, Jeffrey B.
,
Knight, Richard
Lecker, Stewart H.
Stillman, Isaac
Amodu, Afolarin A.
Ilori, Titlayo
Maikhor, Shana
Schmidt, Insa
McMahon, Gearoid M.
Weins, Astrid
Hacohen, Nir
Bush, Lakeshia
Gonzalez-Vicente, Agustin
Taliercio, Jonathan
O’toole, John
Poggio, Emilio
Cooperman, Leslie
Jolly, Stacey
Herlitz, Leal
Nguyen, Jane
Palmer, Ellen
Sendrey, Dianna
Spates-Harden, Kassandra
Appelbaum, Paul
Barasch, Jonathan M.
Bomback, Andrew S.
D’Agati, Vivette D.
Mehl, Karla
Canetta, Pietro A.
Shang, Ning
Balderes, Olivia
Kudose, Satoru
Barisoni, Laura
Alexandrov, Theodore
Cheng, Yinghua
Dunn, Kenneth W.
Kelly, Katherine J.
Sutton, Timothy A.
Wen, Yumeng
Corona-Villalobos, Celia P.
Menez, Steven
Rosenberg, Avi
Atta, Mohammed
Johansen, Camille
Sun, Jennifer
Roy, Neil
Williams, Mark
Azeloglu, Evren U.
He, Cijang
Iyengar, Ravi
Hansen, Jens
Xiong, Yuguang
Rovin, Brad
Parikh, Samir
Madhavan, Sethu M.
Anderton, Christopher R.
Pasa-Tolic, Ljiljana
Velickovic, Dusan
Troyanskaya, Olga
Sealfon, Rachel
Tuttle, Katherine R.
Laszik, Zoltan G.
Nolan, Garry
Sarwal, Minnie
Anjani, Kavya
Sigdel, Tara
Ascani, Heather
Balis, Ulysses G. J.
Lienczewski, Chrysta
Steck, Becky
He, Yougqun
Schaub, Jennifer
Blanc, Victoria M.
Murugan, Raghavan
Randhawa, Parmjeet
Rosengart, Matthew
Tublin, Mitchell
Vita, Tina
Kellum, John A.
Hall, Daniel E.
Elder, Michele M.
Winters, James
Gilliam, Matthew
Alpers, Charles E.
Blank, Kristina N.
Carson, Jonas
De Boer, Ian H.
Dighe, Ashveena L.
Himmelfarb, Jonathan
Mooney, Sean D.
Shankland, Stuart
Williams, Kayleen
Park, Christopher
Dowd, Frederick
McClelland, Robyn L.
Daniel, Stephen
Hoofnagle, Andrew N.
Wilcox, Adam
Bansal, Shweta
Sharma, Kumar
Venkatachalam, Manjeri
Zhang, Guanshi
Pamreddy, Annapurna
Kakade, Vijaykumar R.
Moledina, Dennis
Shaw, Melissa M.
Ugwuowo, Ugochukwu
Arora, Tanima
Ardayfio, Joseph
Bebiak, Jack
Brown, Keith
Campbell, Catherine E.
Saul, John
Shpigel, Anna
Stutzke, Christy
Koewler, Robert
Campbell, Taneisha
Hayashi, Lynda
Jefferson, Nichole
Pinkeney, Roy
Roberts, Glenda V.
Eadon, Michael T. https://orcid.org/0000-0003-3066-2876
Dagher, Pierre C. https://orcid.org/0000-0003-3321-5561
El-Achkar, Tarek M. https://orcid.org/0000-0003-4645-3614
Zhang, Kun https://orcid.org/0000-0002-7596-5224
Kretzler, Matthias https://orcid.org/0000-0003-4064-0582
Jain, Sanjay https://orcid.org/0000-0003-2804-127X
- License Information
-
More Information
Article History
Received: 31 July 2021
Accepted: 30 January 2023
First Online: 19 July 2023
Change Date: 26 September 2023
Change Type: Update
Change Details: An amendment to the underlying code was made to enable an author name to appear correctly in PubMed.
Competing interests
: P.V.K. serves on the scientific advisory board to Celsius Therapeutics and Biomage. A.V. is a consultant for Astute and NxStage. C.R.P. is a member of the advisory board of and owns equity in RenalytixAI, and serves as a consultant for Genfit and Novartis. M.K. has grants from JDRF, Astra-Zeneca, NovoNordisc, Eli Lilly, Gilead, Goldfinch Bio, Janssen, Boehringer-Ingelheim, Moderna, European Union Innovative Medicine Initiative, Chan Zuckerberg Initiative, Certa, Chinook, amfAR, Angion Pharmaceuticals, RenalytixAI, Travere Therapeutics, Regeneron, IONIS Pharmaceuticals, Astellas, Poxel and a patent (PCT/EP2014/073413; ‘Biomarkers and methods for progression prediction for chronic kidney disease’) licensed. F.C. and E.Z.M. are paid consultants for Atlas Bio. F.P.W. receives research support from Astrazeneca, Boeringher-Ingelheim, Vifor Pharma and Whoop. P.M.P. is a consultant for Janssen. S.R. has research funding from AstraZeneca and Bayer Healthcare. S.S.W. is a consultant for GSK, GEHC, JNJ, Strataca, Roth Capital Partners, Venbio, and an expert witness on litigation for Davita and Pfizer. J.R.S. consults for Maze and Goldfinch and receives royalties from Sanfi Genzyme. K.Z. is a co-founder, equity holder and serves on the scientific advisory board of Singlera Genomics. A.S.N. is on the external advisory board for CareDX. L.H.M. is a consultant for Reata Pharmaceuticals, Travere Therapeutics and Calliditas. S.J. is a paid Blue SKy mentor for Meharry Medical College, Nashville and receives royalties from Elsevier. J.L.M. is an employee and shareholder of Solid Biosciences. The other authors declare no competing interests.
